CoreCap Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
CoreCap Advisors's BIIB Position: Q3 2026 in Review
CoreCap Advisors increased its Biogen (BIIB) stake by 23% in Q3 2026, buying an estimated $42.2K and bringing the position to 1,057 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #781.
CoreCap Advisors first reported a position in BIIB in Q4 2021 and has held it in 14 quarters since. The position peaked at $2.06M in Q4 2022. 207 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- CoreCap Advisors held 1,057 shares of Biogen worth $239K as of Q3 2026.
- CoreCap Advisors bought 199 Biogen shares in Q3 2026, an estimated $42.2K.
- Biogen made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #781 holding.
- CoreCap Advisors first reported a position in Biogen in Q4 2021 and has held it in 14 quarters since.
- CoreCap Advisors's Biogen position peaked at $2.06M in Q4 2022.
- 207 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.